Novel toxicology challenges in the era of chimeric antigen receptor T-cells therapies

Kentaro Minagawa, Antonio Di Stasi

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)S444-S449
JournalTranslational Cancer Research
Volume5
DOIs
StatePublished - Jan 1 2016

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

@article{b6e22237672d40499f0f35fda3857b5a,
title = "Novel toxicology challenges in the era of chimeric antigen receptor T-cells therapies",
author = "Kentaro Minagawa and {Di Stasi}, Antonio",
year = "2016",
month = "1",
day = "1",
doi = "10.21037/tcr.2016.09.06",
language = "English (US)",
volume = "5",
pages = "S444--S449",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

Novel toxicology challenges in the era of chimeric antigen receptor T-cells therapies. / Minagawa, Kentaro; Di Stasi, Antonio.

In: Translational Cancer Research, Vol. 5, 01.01.2016, p. S444-S449.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Novel toxicology challenges in the era of chimeric antigen receptor T-cells therapies

AU - Minagawa, Kentaro

AU - Di Stasi, Antonio

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84992111165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992111165&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.09.06

DO - 10.21037/tcr.2016.09.06

M3 - Editorial

AN - SCOPUS:84992111165

VL - 5

SP - S444-S449

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -